The Kansas City AIDS consortium is closing after eleven years of providing experimental drug treatments to AIDS victims in the area. The consortium says new, effective, available drugs are making it harder to find people to try experimental drugs. The consortium has about 150 patients enrolled in seven drug trials. It will try to find someone else to finish those studies.